Today: 4 March 2026
Subscribe
Browse Category

Stock Market 30 October 2025

Salesforce Stock Soars After Dreamforce AI Bombshell – What Investors Need to Know (Oct. 21, 2025)

Salesforce (CRM) Stock Rockets After $60B Dreamforce AI Bombshell – Can the Rally Last?

Salesforce shares traded near $258.65 on Oct. 30, 2025, down about 27% from early-year highs and underperforming the S&P 500. Q2 revenue reached $10.24 billion, beating estimates, but cautious Q3 guidance triggered a 5–8% sell-off in September. CEO Marc Benioff’s AI roadmap and $60 billion 2030 target briefly lifted the stock at Dreamforce. Analyst price targets range widely, with consensus at Moderate Buy.
30 October 2025
··
IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?

AI & Quantum Sparks a Big Blue Comeback – IBM Stock Rallies (But Will it Last?)

IBM shares closed near $308 on Oct. 29, 2025, up about 30% year-to-date, after multi-year highs driven by AI and quantum advances. Q3 earnings beat estimates, with revenue at $16.33 billion and adjusted EPS of $2.65; IBM raised full-year guidance. Cloud and Red Hat growth slowed, prompting a 5% after-hours drop on Oct. 22. IBM trades at a forward P/E in the mid-20s and yields a 2.3% dividend.
30 October 2025
·······
SAP Stock Skyrockets on Cloud Boom – Analysts Eye New Highs?

SAP Stock Soars on Cloud Surge — Can the Rally Continue?

SAP shares traded near $262 on Oct. 30, 2025, roughly flat for the year after a 75% surge over 12 months. Q3 revenue rose 7% to €9.08 billion, with cloud sales up 22% and backlog at a record €18.84 billion. SAP raised its 2025 profit outlook but expects cloud revenue at the low end of guidance. The stock swung sharply after earnings, closing between $259 and $279 during the week.
30 October 2025
··
Quantum Breakthrough or Bubble? Rigetti Stock Rockets 5,000% in 2025

Quantum Breakthrough or Bubble? Rigetti Stock Rockets 5,000% in 2025

Rigetti Computing shares soared nearly 5,000% in 2025, peaking at $56 in mid-October before dropping to the high $30s. The company won a $5.8 million U.S. Air Force contract and launched a 36-qubit processor, but Q2 revenue was just $1.8 million against a $39.7 million net loss. Market cap reached $12–17 billion, drawing analyst warnings of overvaluation. U.S. policy speculation fueled further volatility.
30 October 2025
··
Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Pfizer shares traded near $24.20 on Oct. 30, 2025, flat for the week and close to the low end of their 52-week range. The stock surged 15% in late September after Pfizer agreed to cut Medicaid drug prices and announced a $7.3 billion deal to acquire obesity-drug maker Metsera. Rival Novo Nordisk countered with a higher bid for Metsera. Q3 earnings are due Nov. 4, with analysts expecting a sharp year-over-year decline.
30 October 2025
··
SoFi Stock Rockets 230% in 2025 on Record Q3 and Fintech Boom

SoFi Stock Rockets 230% in 2025 on Record Q3 and Fintech Boom

SoFi shares surged 230% year-over-year, closing at $31.66 after Q3 earnings on Oct. 28 before slipping to around $29.90 by Oct. 30. The company beat Q3 forecasts with $950 million in adjusted net revenue and raised its 2025 guidance. Analysts remain split, with targets ranging from $18 to $36. Cathie Wood’s ARK Invest doubled its stake last quarter, while institutional ownership stands near 48%.
30 October 2025
···
Nokia (NOK) Stock Soars on $1B Nvidia Deal & Massive 5G Contract Wins

Nokia (NOK) Stock Soars on $1B Nvidia Deal & Massive 5G Contract Wins

Nokia shares surged 20–25% in late October 2025, reaching multi-year highs after strong Q3 results and news of a $1 billion investment from NVIDIA for a 2.9% stake. The companies announced a strategic AI and 6G networking partnership. Nokia’s Q3 sales rose 12% to €4.83 billion, beating forecasts, with operating profit at €435 million. Major 5G and network contracts were secured with Vodafone, Rakuten, Elisa, and E.ON.
30 October 2025
··
Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford shares jumped 10% after Q3 earnings beat forecasts, closing near a one-year high at around $13. Revenue hit $50.5 billion, up 9% year-over-year, but the company cut 2025 profit guidance by up to $2 billion due to a supplier fire. Ford’s EV unit continues to post losses, and the automaker faces record recalls and higher labor costs. The dividend resumed at $0.15 per share, with most analysts rating the stock a “Hold.”
30 October 2025
···
Explosive Rally and Volatility: Bitcoin’s Surge Propels Bitfarms Stock

Explosive Rally and Volatility: Bitcoin’s Surge Propels Bitfarms Stock

Bitfarms Ltd. (NASDAQ: BITF) stock surged from about $1 in January to over $6 in mid-October 2025, before dropping nearly 40% and rebounding to around $4.90 by Oct. 27. The company raised $588 million in convertible notes to fund a new Pennsylvania data center and expand into AI infrastructure. Bitfarms also announced a CFO transition and moved its headquarters to the U.S. Analyst targets remain mixed amid ongoing losses.
30 October 2025
···
TeraWulf (WULF) Stock Skyrockets 100% on Google-Backed AI Bet – Clean-Energy Bitcoin Miner Takes Off

TeraWulf (WULF) Stock Skyrockets 100% on Google-Backed AI Bet – Clean-Energy Bitcoin Miner Takes Off

TeraWulf shares surged 17% on Oct. 28, 2025, after announcing a $9.5 billion, 25-year joint venture with Fluidstack and Google to build a 168 MW AI compute campus in Texas. The stock pulled back 9% the next day, closing near $14.50. Year-to-date, WULF is up about 117%. Q3 revenue was pre-announced at $42 million, up 84% year-over-year, with full results due Nov. 10.
30 October 2025
···
Sprouts Farmers Market Stock Plunges 25% on Mixed Q3 Earnings – Analysts Scramble

Sprouts Farmers Market Stock Plunges 25% on Mixed Q3 Earnings – Analysts Scramble

Sprouts Farmers Market shares plunged 25% to near $82 on Oct. 30 after Q3 revenue missed estimates and management cut its Q4 sales outlook. Net sales rose 13% to $2.20 billion and EPS beat forecasts, but Q4 comparable-store growth was guided to just 0–2%. UBS and BMO lowered price targets, citing slowing momentum. The stock’s technical indicators showed severe oversold conditions.
30 October 2025
··
Record-Breaking Rally after Trump-Xi Trade Truce – What It Means

Record-Breaking Rally after Trump-Xi Trade Truce – What It Means

Presidents Trump and Xi agreed Oct. 30 to a one-year pause in their tariff war, with China delaying rare-earth export controls and resuming U.S. soybean and energy purchases. The U.S. will cut some tariffs, including halving its fentanyl-related levy. Global stocks hit records ahead of the deal, but markets turned cautious after the announcement. Major issues like tech sanctions and Taiwan remain unresolved.
30 October 2025
···
China–Russia Mega Trade Deal Jolts Markets: Stocks React to New Pact

China–Russia Mega Trade Deal Jolts Markets: Stocks React to New Pact

Russia’s parliament ratified a new investment and trade treaty with China on Oct. 27, including the Power of Siberia-2 gas pipeline memorandum and plans to settle more trade in yuan and rubles. China’s Shanghai Composite and Hong Kong’s Hang Seng fell, while Russia’s MOEX rose. Bilateral trade reached $244.8 billion in 2024 but dropped 9% in early 2025. Oil and gold prices climbed following the announcement.
30 October 2025
····
CVU Stock Skyrockets 70% on Missile Contract Win – CPI Aerostructures Surges as Analysts Weigh In

CVU Stock Skyrockets 70% on Missile Contract Win – CPI Aerostructures Surges as Analysts Weigh In

CPI Aerostructures shares surged up to 75% intraday on Oct. 30 after announcing a major missile wing contract with Raytheon. The stock traded around $3.50–$3.70 by late morning, reversing from 52-week lows earlier in the week. The new order expands CPI’s presence in missile systems, with deliveries starting in 2026. Financial terms were not disclosed.
30 October 2025
···
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience shares fell to $0.40 in October 2025, down 84% year-over-year, after hitting a 52-week low of $0.28. Nasdaq granted a 180-day extension to regain $1 compliance, and the company is considering a reverse split. Q2 revenue dropped 12% to $20.5 million, but cash flow improved. Debt refinancing is required by December 2025, and John Duke became CEO in July after Jim Green’s retirement.
30 October 2025
··
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”

Oracle shares closed near $269 on Oct. 30, down from September highs but up 70% year-to-date as AI/cloud deals fueled gains. Q1 FY26 revenue rose 12% to $14.93 billion, with cloud sales up 28%. Reports cite major unconfirmed deals with OpenAI and Meta, driving RPO to $455 billion. Analyst targets cluster around $320–$400, but Oracle’s valuation remains high compared to rivals.
30 October 2025
···
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Rockets to $5 Trillion Valuation – AI Frenzy Fuels Record Highs

Nvidia became the first U.S. company to surpass $5 trillion in market value on Oct 29, closing at $207.04 per share. The stock pulled back about 1.4% to $204–$205 on Oct 30. Year-to-date, Nvidia shares are up roughly 50%, driven by surging AI chip demand and major deals with OpenAI and the U.S. Department of Energy. Rival AMD also announced a large AI chip deal with OpenAI.
30 October 2025
···
Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power’s 170% Hydrogen Rally Cools – Can PLUG Stock Reignite?

Plug Power shares soared about 170% from late summer lows to a $4.58 peak in early October, then dropped to around $2.8–$2.9 by Oct. 30. The company signed a 2 GW electrolyzer deal in Uzbekistan, raised $370 million, and secured major credit lines. Founder CEO Andy Marsh will step down in 2026. Analysts remain split, with targets ranging from $1 to $4.50.
30 October 2025
······
1 … 1,226 1,227 1,228 1,229 1,230 … 1,332
Go toTop